BioSpace News Archive

Matt Monaghan, chairman, president and chief executive officer of Invacare Corporation (NYSE:IVC), will participate in a fireside chat at the Stephens Nashville Investment Conference at the Omni Nashville Hotel in Nashville, TN on Thursday, November 14, 2019 at 9:45 a.m. CT.

Continued progress towards 2022 vision of four marketed gene and cell therapy products with robust development pipeline

AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in healthcare workforce solutions and staffing services, today announced its third quarter 2019 financial results.

GB Sciences, Inc. is pleased to announce that on October 23rd Mr. Edmond DeFrank joined its Board of Directors, filling a vacant seat.

Dr. Chaudhary has over 16 years of experience within the biotech and large pharmaceutical industry with broad experience in strategic business development and drug discovery.

Foresite Labs supports creative entrepreneurs working to solve our greatest unmet medical needs

Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, and Catalent Biologics’ Paragon Gene Therapy unit, the leading viral vector development and manufacturing partner for gene therapies, today announced the closing of their previously announced arrangement.

SeraCare Life Sciences, part of the LGC Clinical Diagnostics Business Unit and a manufacturer and leading partner to global in vitro diagnostics manufacturers and clinical laboratories, announced today the commercial release of the first ever genomic DNA (gDNA) and formalin-fixed paraffin-embedded (FFPE) reference materials for tumor mutational burden (TMB) measurement by next-generation sequencing (NGS) assays

The Alzheimer’s Association and The African Methodist Episcopal Church announced a new three-year partnership aimed at educating and engaging more than 2 million U.S.-based AME Church members in the fight against Alzheimer’s.

Blue Biotechnology Trends That Will Disrupt the Market: Derivation of Active Ingredients from Aquatic Organisms